EP Patent

EP4046629A1 — Lipid nanoparticle compositions and methods of formulating the same

Assigned to ModernaTx Inc · Expires 2022-08-24 · 4y expired

What this patent protects

Provided herein are compositions and methods of reducing adduct formation.

USPTO Abstract

Provided herein are compositions and methods of reducing adduct formation.

Drugs covered by this patent

Patent Metadata

Patent number
EP4046629A1
Jurisdiction
EP
Classification
—
Expires
2022-08-24
Drug substance claim
No
Drug product claim
No
Assignee
ModernaTx Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.